Investigating autophagy and mitophagy in 12Z endometriosis cells via exposure to pharmacological inhibitors

article OA: green CC0

Abstract

Endometriosis is a chronic condition in which endometrial tissue spreads outside the uterus and causes inflammation. As these cells enter oxidative stress conditions, they rely on autophagy and mitophagy–cellular recycling mechanisms–to survive. Thwarting these processes may prohibit further growth. This experiment applied medications suspected to inhibit autophagy and mitophagy to endometriosis cells to study the effects on growth and protein pathways. Endometriosis 12Z cells were cultured and divided into two assays. In the first, cells were treated with chloroquine phosphate, metformin, lidocaine, or combinations of these for different time stamps. After treatment, cells were lysed and analyzed using reverse phase protein array (RPPA). In the second experiment, endometriosis cells were cultured and scratched to assess migration and growth response to metformin, lidocaine, tamoxifen, and chloroquine phosphate. Following treatment, cells were lysed and analyzed using western blot, RPPA, and immunohistochemistry. Morphological analysis of 12Z cells in the first experiment revealed responses to chloroquine phosphate, including rod-shaped distortion, refractility, and large cytoplasmic vacuoles. These effects were amplified by co-treatment with lidocaine or metformin, leading to pronounced cell swelling and vacuolization—signs of disrupted autophagy. Preliminary data suggests that 12Z cells exposed to drugs, such as chloroquine phosphate, left wider gaps in scratch assays, suggesting slower growth and increased stress responses. Metformin+Lidocaine increased PHGDH, Calbindin, and AMPK alpha Thr172 in the 48-hour time course. Chloroquine phosphate increased proteins in glucose, autophagy, and oxidative stress pathways. Chloroquine-treated cells induced autophagy-disruption and stress, while Metformin+Lidocaine elevated the levels of autophagy pathway proteins. Ongoing research aims to investigate the pathways involved.
Full text 2,238 characters · extracted from oa-html · click to expand
Investigating autophagy and mitophagy in 12Z endometriosis cells via exposure to pharmacological inhibitors DOI: https://doi.org/10.13021/jssr2025.5187Abstract Endometriosis is a chronic condition in which endometrial tissue spreads outside the uterus and causes inflammation. As these cells enter oxidative stress conditions, they rely on autophagy and mitophagy–cellular recycling mechanisms–to survive. Thwarting these processes may prohibit further growth. This experiment applied medications suspected to inhibit autophagy and mitophagy to endometriosis cells to study the effects on growth and protein pathways. Endometriosis 12Z cells were cultured and divided into two assays. In the first, cells were treated with chloroquine phosphate, metformin, lidocaine, or combinations of these for different time stamps. After treatment, cells were lysed and analyzed using reverse phase protein array (RPPA). In the second experiment, endometriosis cells were cultured and scratched to assess migration and growth response to metformin, lidocaine, tamoxifen, and chloroquine phosphate. Following treatment, cells were lysed and analyzed using western blot, RPPA, and immunohistochemistry. Morphological analysis of 12Z cells in the first experiment revealed responses to chloroquine phosphate, including rod-shaped distortion, refractility, and large cytoplasmic vacuoles. These effects were amplified by co-treatment with lidocaine or metformin, leading to pronounced cell swelling and vacuolization—signs of disrupted autophagy. Preliminary data suggests that 12Z cells exposed to drugs, such as chloroquine phosphate, left wider gaps in scratch assays, suggesting slower growth and increased stress responses. Metformin+Lidocaine increased PHGDH, Calbindin, and AMPK alpha Thr172 in the 48-hour time course. Chloroquine phosphate increased proteins in glucose, autophagy, and oxidative stress pathways. Chloroquine-treated cells induced autophagy-disruption and stress, while Metformin+Lidocaine elevated the levels of autophagy pathway proteins. Ongoing research aims to investigate the pathways involved. Published Issue Section License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-10T11:50:10.104909+00:00
License: CC0 · commercial use OK